Wandercraft, a Paris-based robotics company, has recently raised $75 million in a Series D funding round, following a €25 million loan from the EIB and a $45 million Series C round, which has significantly boosted its growth and expansion into the U.S. market.

This funding has contributed to a tenfold revenue increase since the last funding round, enhancing Wandercraft's global visibility and product innovation.

The new capital will support the commercialization of Eve, the first self-balancing personal exoskeleton, expected to launch in 2026, and will also enhance the Atalante X rehabilitation system and develop the Calvin-40 humanoid robot.

Eve is designed for individuals with severe mobility loss, allowing wheelchair users to stand and walk in everyday situations, and is currently undergoing clinical trials to assess its usability.

Wandercraft has begun enrolling participants in these clinical trials for its Personal Exoskeleton system, further enhancing its research and development efforts.

The Atalante X exoskeleton has already received FDA clearance and is currently in use across over 100 hospitals globally, helping 2,500 individuals with mobility disabilities take over 14 million steps.

To further support its mission, Wandercraft has established a center in New York City called 'Walk in New York', offering exoskeleton sessions for individuals with mobility impairments.

As the lower-limb exoskeleton market is expected to grow significantly from 2025 to 2030, driven by an aging population, Wandercraft's technology offers a competitive edge in this expanding market.

Despite its successes, Wandercraft faces challenges such as scaling production, navigating regulatory approval timelines, and achieving market adoption.

The existing Atalante X exoskeleton is priced at €200,000 and has sold 110 units primarily in France, while also gaining traction in the U.S. market.

In addition to its rehabilitation technologies, Wandercraft is developing the Calvin line of autonomous humanoid robots, designed to assist workers in physically demanding tasks.

Wandercraft's innovations have garnered multiple accolades, including a 2025 Innovation Award at SXSW and recognition in the FT120 Index for leading startups in France.